The FDA has approved a less-invasive, first-of-its-kind heart defibrillator, developed by Boston...

|About: Boston Scientific Corporation (BSX)|By:, SA News Editor

The FDA has approved a less-invasive, first-of-its-kind heart defibrillator, developed by Boston Scientific's (BSX) Cameron Health, that does not directly touch the heart. Implantable defibrillators use thin wires traditionally connected to the heart through a blood vessel in the upper chest. The new device from BSX uses wires that sit just below the skin's surface and do not need to be threaded through the heart's blood vessels.